Type One Energy Raises $29M
Type One Energy has closed on a $29 million financing round, the organization announced today. According to a release, the funding was co-led by Breakthrough Energy Ventures (BEV), TDK Ventures…
Category Archives: Biotech
NorthStar Receives Electron Beam Accelerator
NorthStar Medical Radioisotopes has received a custom-built IBA Rhodotron TT 300-HR electron beam accelerator to its new Ac-225 Production facility, the organization announced recently. According to a release, the accelerator…
Promega Launches Wastewater Testing Kit
Promega announced recently that it has launched a wastewater testing kit that pairs its Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles, an established technology for capturing and concentrating low-abundance…
JangoCell, Captivate Bio Partner on Distribution
JangoCell, a subsidiary of JangoBio, has entered into a distribution partnership for Captivate Bio’s culture media, balanced salt solutions, small molecules and other culture reagents, the company announced recently. “JangoCell…
Nimble Therapeutics, Genentech Partnership Expands
Nimble Therapeutics has expanded its collaboration and executed a license agreement with Genentech, the company announced recently. According to a release, the two companies will work together on the discovery…
NorthStar Collaborates With Inhibrx
NorthStar Medical Radioisotopes is collaborating with Inhibrx, a biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, the company announced recently. According to a release, the…
Voximetry Gets FDA Clearance
Voximetry received 510(k) market clearance from the U.S. Food and Drug Administration for its Torch Dose Assessment for Radiopharmaceutical Therapy, the company announced recently. According to a release, Torch can…
Plumb Pharmaceuticals Gets Investment from Winnow Fund
Plumb Pharmaceuticals announced recently that it received an investment from the Winnow Fund earlier this year. The company did not reveal the investment amount. Plumb Pharmaceuticals is currently developing its…
Venture Investors, SWIB Invest in HistoSonics
Venture Investors and the State of Wisconsin Investment Board participated in a $100 million financing round for HistoSonics, which made the announcement today. The Minneapolis-based HistoSonics is a developer of…
Exact Sciences’ POLAR Predicts Therapy Benefit
Exact Sciences’ announced today its initial clinical validation data for its Profile for the Omission of Local Adjuvant Radiotherapy (POLAR). According to a release, POLAR is the first genomic signature…
